[144] Bilibili Inc. American SEC Filing
Rhea-AI Filing Summary
Bilibili Inc. (BILI) filed a Form 144 notifying the proposed sale of 1,266,204 American Depositary Shares (ADS), each representing one class Z ordinary share, through Morgan Stanley & Co. LLC on NASDAQ with an aggregate market value of $28,211,025.00. The ADS were acquired as founder shares from the issuer on 03/28/2018 and the approximate sale date listed is 09/11/2025. The filing indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR Insiders plan to sell a sizable block of ADS valued at ~$28.2M through a major broker; market reaction depends on context and disclosure.
The filing shows a planned sale of 1,266,204 ADS acquired as founder shares in 2018, to be executed via Morgan Stanley on NASDAQ on or about 09/11/2025. As a Form 144, this is a regulatory notice of intended resale by an affiliate and does not by itself confirm execution or motives. Investors typically view such notices as increased insider liquidity; material market impact depends on trading volume, timing relative to other disclosures, and whether additional insider sales follow.
TL;DR This is a routine Form 144 disclosure of founder-share resale, reflecting compliance with Rule 144 resale requirements.
The disclosure documents the source of the shares as founder shares from the issuer and includes the seller's representation regarding lack of undisclosed material adverse information. The use of a major broker indicates standard execution channels. The filing does not state any trading plan (such as a Rule 10b5-1 plan) or provide further governance context, so no conclusions about intent or governance changes can be drawn from the form alone.